L. Dolcetti
Immunology · 2006–2010
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Immunology — 88 citations into it; #1,771 of 2,160 by trust here, #660 by citations
Whom L. Dolcetti trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Dolcetti overall
Papers from L. Dolcetti's perspective
Ordered by how strongly the researchers L. Dolcetti trusts endorse each paper. Same corpus, a different order for every researcher.
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (Nature Reviews. Cancer)
- Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (Journal of Clinical Investigation)
- Altered macrophage differentiation and immune dysfunction in tumor development. (Journal of Clinical Investigation)
- Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
- Cancer immunoediting: from immunosurveillance to tumor escape (Nature Immunology)
- Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function (Journal of Experimental Medicine)
- Immunosuppressive strategies that are mediated by tumor cells. (Annual Review of Immunology)
- Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 (Journal of Immunology)
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein (Journal of Experimental Medicine)
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells (Nature)
Their papers
- Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function (2006) — 770 citations
- Myeloid-derived suppressor cell heterogeneity and subset definition. (2010) — 675 citations
- Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. (2010) — 894 citations
- Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells (2008) — 624 citations
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. (2006) — 897 citations